Insufficient scRNA-seq data for expression of IFNB1 at single-cell level.
Insufficient scRNA-seq data for expression of IFNB1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 41% | 1.47 | 98 / 241 | 0% | 0 | 0 / 0 |
ovary | 18% | 0.54 | 33 / 180 | 6% | 0.11 | 27 / 430 |
lung | 22% | 0.57 | 126 / 578 | 1% | 0.02 | 12 / 1155 |
thymus | 22% | 0.70 | 142 / 653 | 0% | 0.01 | 2 / 605 |
bladder | 19% | 0.57 | 4 / 21 | 2% | 0.08 | 12 / 504 |
peripheral blood | 21% | 0.88 | 194 / 929 | 0% | 0 | 0 / 0 |
intestine | 17% | 0.40 | 160 / 966 | 0% | 0.00 | 1 / 527 |
adrenal gland | 16% | 0.48 | 41 / 258 | 0% | 0 | 0 / 230 |
uterus | 14% | 0.32 | 24 / 170 | 2% | 0.02 | 7 / 459 |
breast | 11% | 0.28 | 50 / 459 | 4% | 0.10 | 50 / 1118 |
prostate | 13% | 0.25 | 31 / 245 | 0% | 0 | 0 / 502 |
kidney | 12% | 0.49 | 11 / 89 | 0% | 0.00 | 2 / 901 |
brain | 12% | 0.31 | 312 / 2642 | 0% | 0.01 | 3 / 705 |
blood vessel | 11% | 0.28 | 149 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 10% | 0.23 | 141 / 1445 | 1% | 0.06 | 2 / 183 |
adipose | 10% | 0.24 | 124 / 1204 | 0% | 0 | 0 / 0 |
skin | 10% | 0.22 | 175 / 1809 | 0% | 0.00 | 1 / 472 |
stomach | 9% | 0.19 | 31 / 359 | 1% | 0.01 | 2 / 286 |
heart | 7% | 0.18 | 62 / 861 | 0% | 0 | 0 / 0 |
liver | 6% | 0.16 | 14 / 226 | 0% | 0.01 | 2 / 406 |
pancreas | 5% | 0.10 | 15 / 328 | 0% | 0 | 0 / 178 |
muscle | 4% | 0.08 | 31 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0140123 | Biological process | negative regulation of Lewy body formation |
GO_0033141 | Biological process | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_0045581 | Biological process | negative regulation of T cell differentiation |
GO_0045087 | Biological process | innate immune response |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0009615 | Biological process | response to virus |
GO_0051607 | Biological process | defense response to virus |
GO_0030101 | Biological process | natural killer cell activation |
GO_0035458 | Biological process | cellular response to interferon-beta |
GO_0045089 | Biological process | positive regulation of innate immune response |
GO_0006959 | Biological process | humoral immune response |
GO_0045343 | Biological process | regulation of MHC class I biosynthetic process |
GO_2000552 | Biological process | negative regulation of T-helper 2 cell cytokine production |
GO_0002250 | Biological process | adaptive immune response |
GO_0098586 | Biological process | cellular response to virus |
GO_0070050 | Biological process | neuron cellular homeostasis |
GO_0060337 | Biological process | type I interferon-mediated signaling pathway |
GO_0002312 | Biological process | B cell activation involved in immune response |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0042100 | Biological process | B cell proliferation |
GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
GO_0071360 | Biological process | cellular response to exogenous dsRNA |
GO_0002323 | Biological process | natural killer cell activation involved in immune response |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0030183 | Biological process | B cell differentiation |
GO_0002286 | Biological process | T cell activation involved in immune response |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005126 | Molecular function | cytokine receptor binding |
GO_0008811 | Molecular function | chloramphenicol O-acetyltransferase activity |
GO_0005132 | Molecular function | type I interferon receptor binding |
GO_0005125 | Molecular function | cytokine activity |
GO_0005515 | Molecular function | protein binding |
Gene name | IFNB1 |
Protein name | Interferon beta Interferon beta (IFN-beta) (Fibroblast interferon) |
Synonyms | IFNB IFB |
Description | FUNCTION: Type I interferon cytokine that plays a key role in the innate immune response to infection, developing tumors and other inflammatory stimuli . Signals via binding to high-affinity (IFNAR2) and low-affinity (IFNAR1) heterodimeric receptor, activating the canonical Jak-STAT signaling pathway resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the interferon response, such as antiviral proteins, regulators of cell proliferation and differentiation, and immunoregulatory proteins . Signals mostly via binding to a IFNAR1-IFNAR2 heterodimeric receptor, but can also function with IFNAR1 alone and independently of Jak-STAT pathways (By similarity). Elicits a wide variety of responses, including antiviral and antibacterial activities, and can regulate the development of B-cells, myelopoiesis and lipopolysaccharide (LPS)-inducible production of tumor necrosis factor (By similarity). Plays a role in neuronal homeostasis by regulating dopamine turnover and protecting dopaminergic neurons: acts by promoting neuronal autophagy and alpha-synuclein clearance, thereby preventing dopaminergic neuron loss (By similarity). IFNB1 is more potent than interferon-alpha (IFN-alpha) in inducing the apoptotic and antiproliferative pathways required for control of tumor cell growth (By similarity). . |
Accessions | P01574 ENST00000380232.4 B5BUQ5 |